Articles Tagged With: drug
-
Data-Sharing Initiative Targets U.S. Drug Overdose Crisis
Public-private partnership aims to strengthen multigovernmental coordination on prevention efforts.
-
Revamping the Daily Pill: Research to Begin on Monthly Pill
Although lowering side effects plays an important role in oral contraceptive compliance, one of the biggest challenges for patients is adhering to the daily schedule of the pill. Forgetting one to three pills per cycle is a frequent problem among 15-51% of users, particularly among adolescents. Lyndra Therapeutics has received a $13 million grant from the Bill & Melinda Gates Foundation and is setting out to remove the daily pill compliance challenge. The company is in early development of a monthly oral contraceptive to provide women with a discreet, noninvasive, reversible contraception option.
-
Report Details Effect of Mifepristone Labeling Change
New research indicates that for Texas providers and patients, the 2016 Food and Drug Administration’s (FDA) new labeling for the abortion drug mifepristone increased access options and brought the proportion of medication abortions in the state into alignment with national data.
-
Rifamycin Delayed-Release Tablets (Aemcolo)
-
Injectable Implant Focus of HIV Treatment/ Prevention Research
Researchers with the University of North Carolina at Chapel Hill and the Centers for Disease Control and Prevention are examining a new drug delivery system that uses dolutegravir, an established HIV drug, in a potential longacting treatment and prevention system. The system has been tested in animal models.
-
Plazomicin (Zemdri)
Plazomicin is an aminoglycoside recently approved by the Food and Drug Administration for treating complicated urinary tract infections.
-
New Recommendations Focus on HIV Antiretrovirals
Clinicians involved in preventing and treating HIV will want to update their knowledge base with recommendations from the International Antiviral Society–USA for the use of antiretroviral drugs.
-
Physician Theft Charges Dropped in Videotape Case
The anesthesiologist at the center of a scandal involving a hospital that videotaped thousands of women in compromised positions is no longer facing theft charges.
-
Opioid Epidemic Brings Patient Safety Risks
The opioid addiction epidemic is introducing a new patient safety risk to healthcare facilities: the possibility of desperate and clever opioid addicts diverting medications from patients, which could leave the provider liable for any consequences.
-
New Prescription Drug Labeling for Pregnant and Nursing Women
The FDA has updated the requirements for the pregnancy and lactation sections of drug labeling to allow pregnant women and their healthcare providers to be better informed about the risks and benefits of medications while pregnant or nursing. This article discusses the new Pregnancy and Lactation Labeling Rule that went into effect in June 2015 and is being phased in over the next three to five years.